Old cells that don't die. They lose the ability to divide, but do not eliminate themselves. Instead, they remain in the body's tissues and spread inflammatory factors that cause damage around. These are zombie cells (cellular senescence), one of the main factors we have identified for aging. For years scientists have been trying to find a way to eliminate them, but without sufficient success. Now, a new study published in Nature Cell Biology by the MRC Laboratory of Medical Sciences and Imperial College London, reveals a new weakness: a protein called GPX4, and a new way to eliminate the zombie cells without harming healthy cells.
The huge review: 10,480 molecules
The team led by researcher Mariantonietta D'Ambrosio performed an automated survey on 10,480 electrophilic molecules (molecules that can bind to proteins in a unique way). They tested which ones kill zombie cells without harming normal cells. Out of 38 promising molecules, it was discovered that a subset of chloroacetamides showed a broad and powerful senolytic effect.
Target: GPX4
Using a technology called activity-based protein profiling, the team discovered that all these molecules attack the same target: GPX4 (Glutathione Peroxidase 4). This is an enzyme whose role is to prevent the accumulation of oxidized lipids. Without it, the cell accumulates oxidative damage like a fire at straws, and eventually dies in a special process called ferroptosis.
Why do zombie cells depend on GPX4?
The team showed something interesting: senescent cells are in a very dangerous state. They are:
- Exhibit high levels of oxidative stress
- accumulates iron in the cells (Fe2+), which encourages oxidation reactions
- are on the "threshold of ferroptosis"
But they managed to stay alive because of GPX4. They increase the production of this protein as a form of protection. Without it, they would die instantly. And here's the opportunity: If we block GPX4, the senescent cells die, but the healthy cells survive.
Proof of concept: crustaceans
The team showed the therapeutic potential in models of 3 types of cancer:
- Melanoma (skin cancer)
- Prostate cancer
- Ovarian cancer
In all models, the combination of standard chemotherapy with a GPX4 inhibitor eliminated not only the primary cancer cells, but also the senescent cancer cells that were responsible for tumor "remodeling" and resistance to treatment.
Why is this so important?
Zombie cells are linked to almost every disease of aging:
- Osteoarthritis (arthritis)
- Type 2 diabetes
- Alzheimer and Parkinson
- Pulmonary fibrosis
- Heart diseases
- Cancer (as research has shown)
Senolytics (drugs that eliminate zombie cells) are one of the hottest areas in aging research. But the existing senolytics, such as Datinib + Quercetin (D+Q), are not specific enough and cause side effects. GPX4 approach is more accurate and expected to be safer.
Next steps
The team is planning now:
- Development of more specific GPX4 inhibitors (fewer side effects)
- Experiments in old mice, not only in cancer models
- Testing effect on other aging diseases
The first clinical trial in humans is planned for 2027-2028. If successful, this could be the next big step in senolytics.
The bottom line
We are slowly understanding more about zombie cells. And every new understanding is an opportunity for treatment. Discovering GPX4 as their "secret weakness" is a big step towards treatments that could add healthy years to our lives, not just stop diseases.
💬 תגובות (0)
היו הראשונים להגיב על המאמר.